Cleavage of GSK‐3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK‐3β activity induced by H2O2
Open Access
- 4 May 2013
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 126 (2) , 234-242
Abstract
Glycogen synthase kinase‐3 beta (GSK‐3β) dysfunction may play an essential role in the pathogenesis of psychiatric, metabolic, neurodegenerative diseases, in which oxidative stress exists concurrently. Some studies have shown that GSK‐3β activity is up‐regulated under oxidative stress. This study evaluated how oxidative stress regulates GSK‐3β activity in human embryonic kidney 293 (HEK293)/Tau cells treated with hydrogen peroxide (H2O2). Here, we show that H2O2 induced an obvious increase of GSK‐3β activity. Surprisingly, H2O2 dramatically increased phosphorylation of GSK‐3β at Ser9, an inactive form of GSK‐3β,while there were no changes of phosphorylation of GSK‐3β at Tyr216. Moreover, H2O2 led to a transient [Ca2+]i elevation, and simultaneously increased the truncation of GSK‐3β into two fragments of 40 kDa and 30 kDa, whereas inhibition of calpain decreased the truncation and recovered the activity of GSK‐3β. Furthermore, tau was hyperphosphorylated at Ser396, Ser404, and Thr231, three most common GSK‐3β targeted sites after 100 μM H2O2 administration in HEK293/Tau cells, whereas inhibition of calpain blocked the tau phosphorylation. In addition, we found that there were no obvious changes of Cyclin‐dependent kinase 5 (CDK5) expression (responsible for tau phosphorylation) and of p35 cleavage, the regulatory subunit of CDK5 in H2O2‐treated HEK293/Tau cells. In conclusion, Ca2+‐dependent calpain activation leads to GSK‐3β truncation, which counteracts the inhibitory effect of Ser9 phosphorylation, up‐regulates GSK‐3β activity, and phosphorylates tau in H2O2‐treated HEK293/Tau cells.Keywords
Funding Information
- National Natural Science Foundation of China (81271405, 31071226)
This publication has 43 references indexed in Scilit:
- Antioxidant Therapies for Alzheimer's DiseaseOxidative Medicine and Cellular Longevity, 2012
- Calpain regulates N-terminal interaction of GSK-3β with 14-3-3ζ, p53 and PKB but not with axinNeurochemistry International, 2011
- Differential Modulation of Akt/Glycogen Synthase Kinase-3β Pathway Regulates Apoptotic and Cytoprotective Signaling ResponsesJournal of Biological Chemistry, 2008
- GLYCOGEN SYNTHASE KINASE 3β AS A TARGET FOR THE THERAPY OF SHOCK AND INFLAMMATIONShock, 2007
- Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and TherapeuticsNeurochemical Research, 2006
- Lithium, a Common Drug for Bipolar Disorder Treatment, Regulates Amyloid-β Precursor Protein ProcessingBiochemistry, 2004
- Glycogen synthase kinase-3β is tyrosine-phosphorylated by MEK1 in human skin fibroblastsBiochemical and Biophysical Research Communications, 2004
- The glamour and gloom of glycogen synthase kinase-3Trends in Biochemical Sciences, 2004
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingProgress in Neurobiology, 2001
- Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25Journal of Biological Chemistry, 2000